Cilostazol in Parkinson's Disease

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Parkinson's Disease
Interventions
DRUG

Cilostazol

2 tablets of 50 mg cilostazol will be received for 4 weeks, then the does will be 2 tablets of 100 mg cilostazol twice daily for 20 weeks

DRUG

Placebo

The patient will receive 2 tablets twice daily

DRUG

Standard treatment

It includes Levodopa with a dose of 375 to 1000mg daily and Dopamine agonists with a dose of 1.5 to 5 mg daily.

Trial Locations (1)

Unknown

Ain Shams University Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06612593 - Cilostazol in Parkinson's Disease | Biotech Hunter | Biotech Hunter